Diapulse Corporation

Medicare approval granted for coverage of wound treatment system

Published in Medical Verdicts and Law Weekly, March 18th, 2004

Diapulse Corporation of America (DIAC) announced that the U.S. Centers for Medicare and Medicaid (CMS) Services has granted approval for coverage of the Diapulse Wound Treatment System in a Decision Memorandum issued December 22, 2003.

Under CMS guidelines the company submitted a Formal Request for Reconsideration outlining an error in a decision that had become effective April 1, 2003, that omitted Diapulse from Medicare coverage for treatment of chronic wounds.

Over a 17-month period, David M. Ross, VP of Diapulse Corporation of America, met with CMS and supplied information that was instrumental in convincing CMS to reverse a previous national...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly

Source: Medical Verdicts and Law Weekly (2004-03-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry